ReviewFrontiers in immunology2018

Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.

Georgina Flórez-Grau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.